Bill Grey

Group Leader, @YBRI_UoY, @LeukUK John Goldman Fellow, @The_MRC CDA fellow. @LSCN_UK founder. Studying proteins in healthy and cancer stem cells.

[Bill Grey @Bill_G_Grey]

8/ This work was led by Dr. Zahra Masoumi, with Navin Shirodkar, Lauren Wheeler, Megan Guthrie, Daniel Davies and Diana Hernandez. Thoughts welcome.

[Bill Grey @Bill_G_Grey]

1/ New preprint from the lab: https://t.co/rWtZVJ0CVJ

In brief:

[Bill Grey @Bill_G_Grey]

7/ Expansion protocols usually treat "more cells" as the goal. If decline isn't an inevitable cost of proliferation, there's room to keep one without paying the other - which is the useful part when thinking about designing new expansion systems and cell therapies for the future.

[Boiers Lab @BoiersLab]

Don’t miss our new preprint!
We mapped chromatin accessibility in human first-trimester HSPCs, revealing key fetal vs adult differences in hematopoiesis.
🔗 https://t.co/nyyjBCxGxH
#Hematopoiesis #StemCells #Chromatin #Epigenetics #LeukemiaResearch

[Simona Valletta @Dr_Valletta]

📢 Join us in Liverpool for the EHA-BSH YERM 2026!
📅 April 18, 2026
📌 Liverpool
Abstract submissions open until February 9, 2026‼️‼️
@Bill_G_Grey @MariaTeresaEs @drnborges @EHA_Hematology
#HSC #microenvironment #Hematology

[Hematopoiesis News @Hema_News]

Dr. Kavita Bisht and team from @TRI_info found that endothelial protein C receptor CD201 is a better marker than SCA1 to identify mouse long-term reconstituting hematopoietic stem cells following septic challenge.

https://t.co/HCAJ3EgtJB

[ISEH @ISEHSociety]

We couldn't agree more - learn more about the contributions of these giants who shaped the field of experimental hematology: https://t.co/aFtu6OmClV #ExpHem

[ISEH @ISEHSociety]

Showcase your research in Experimental Hematology, the ISEH journal dedicated to transformative hematology science. Take advantage of fast-track options, open access discounts, and global visibility for your work. Learn more: https://t.co/ZlyraCuD8X

[ISEH @ISEHSociety]

This month on #SimplyBlood 🩸 we're featuring the Cancer and Bone Lab at The University of Sheffield, UK. Led by Alanna Green, the lab played a central role in developing a new drug to clinical trials for myeloma patients. Read more on https://t.co/HfAjEiYwlB

[WolfLabs @wolflabsuk]

Meet @jmf506 @UofYTechs, Senior Technical Manager at the @BiologyatYork — our latest Technician Under the Microscope! From autoclaves to blood for research, no two days are the same. Read his story & advice 👇
https://t.co/tikirbQXZW

#TechniciansUnderTheMicroscope #LabLife

[Dave Boucher @dave_boucher]

Three PhD positions open in the lab for British Students. Inflammasome, cell death and skin immunity, with fantastic colleagues. Check them out or shared it with curious and motivated prospective PhD students: https://t.co/OMxKvrrnGr @BBSRC @YBRI_UoY @BiologyatYork

[Bill Grey @Bill_G_Grey]

All #PhD adverts are now live for applications with deadlines approaching: https://t.co/VGtk6erwVY

[Bill Grey @Bill_G_Grey]

🚨 We have 3 fully funded PhD studentships open!
Join the Grey Lab & collaborators at @BiologyatYork @UniversityLeeds & @YBRI_UoY to explore stem cells, proteomics & leukaemia biology
📍Start Oct 2026 | 💡Apply via MRC & BBSRC
👇Details in thread 👇

[Bill Grey @Bill_G_Grey]

Reach out to me at [email protected] for any informal enquiries.

[Bill Grey @Bill_G_Grey]

🚨 We have 3 fully funded PhD studentships open!
Join the Grey Lab & collaborators at @BiologyatYork @UniversityLeeds & @YBRI_UoY to explore stem cells, proteomics & leukaemia biology
📍Start Oct 2026 | 💡Apply via MRC & BBSRC
👇Details in thread 👇

[Bill Grey @Bill_G_Grey]

PhD: Targeting Therapy-Resistant Leukaemic Stem Cells in AML
Use proteomics, CRISPR & holotomographic imaging to expose how leukaemic stem cells evade therapy — and how to stop them.
🧠 Start Oct 2026
💫 Apply via DiMeN DTP
👉 Details: [https://t.co/x4UQdZOJ7D]